Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Endometrial cancer starts when cells in the endometrium (the inner lining of the uterus) begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other parts of the body.
The uterus is a hollow organ, normally about the size and shape of a medium-sized pear. The uterus is where a fetus grows and develops during pregnancy. During childbearing years, the body's ovaries typically release an egg every month, and hormones cause the lining of the endometrium to grow and thicken in preparation for pregnancy. If pregnancy doesn't occur, this endometrial lining sheds through the vagina, a process known as menstruation. This process continues to occur each month until menopause, when the ovaries stop releasing eggs and producing female hormones.
The uterus has 3 sections:
When people talk about uterine cancer, they usually mean cancers that start in the body of the uterus, not the cervix. (Cervical cancer is a different type of cancer.)
The body of the uterus has 3 main layers:
Endometrial cancer (also called endometrial carcinoma) starts in the cells of the inner lining of the uterus (the endometrium). This is the most common type of uterine cancer.
Endometrial carcinomas are classified by how the cells look under the microscope. These are called histologic types and are classified by the World Health Organization (WHO); They include:
Most endometrial cancers are adenocarcinomas. Endometrioid carcinoma is the most common type of adenocarcinoma. Endometrioid adenocarcinoma start in gland cells and look a lot like the normal uterine lining (endometrium).
Uterine carcinosarcoma (CS) starts in the endometrium and has features of both endometrial carcinoma and sarcoma. A sarcoma is a cancer that starts in muscle cells of the uterus. In the past, CS was considered a different type of uterine cancer called uterine sarcoma (see below), but doctors now believe that uterine CS is an endometrial carcinoma that's has grown so abnormally that it no longer looks like the cells from which it came, the endometrium. Uterine CS are also known as malignant mixed mesodermal tumors or malignant mixed mullerian tumors (MMMTs). They make up about 3% of uterine cancers.
Uterine sarcomas start in the muscle layer (myometrium) or supporting connective tissue of the uterus. These include uterine leiomyosarcomas and endometrial stromal sarcomas. These cancers are not covered here but are discussed in detail in Uterine Sarcoma.
Cancers that start in the cervix and then spread to the uterus are different from cancers that start in the body of the uterus. They're described in Cervical Cancer.
Endometrial cancers were traditionally categorized into two types, based on whether the cancer cells are dependent on estrogen.
Type 1 endometrial cancers are the most common type. They are mostly endometroid adenocarcinomas and depend on estrogen for growth. Type 1 cancers are usually not very aggressive and don't spread to other tissues quickly. They sometimes develop from atypical hyperplasia, an abnormal overgrowth of cells in the endometrium. (See Endometrial Cancer Risk for more on this.)
Type 2 endometrial cancers are mostly serous carcinomas and do not depend on estrogen for growth. These types of cancers have poorer outlook compared to Type 1. Doctors tend to treat these cancers more aggressively.
Endometrial cancer also is given a grade based the percentage of cancer cells present. Cancer cells are identified when the pathologist sees a solid non-glandular growth.
The lower-grade cancers are grades 1 and 2 endometrial cancers. The higher-grade cancers are grade 3 endometrial cancer, as well as all serous adenocarcinoma, clear cell adenocarcinoma, mixed carcinoma, undifferentiated carcinomas, and carcinosarcomas.
In addition to the WHO classification, endometrial cancers can be further classified into molecular subtypes. Assigning an endometrial cancer into a particular molecular sub-type is based on the mutation found in a cancer cell. Identification of the specific subtype of endometrial cancer can help doctors understand the likelihood of the cancer recurring after treatment, and as well which treatment would be most effective. There are 4 molecular subtypes of endometrial cancer:
A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor can grow but generally will not spread to other body parts.
Benign conditions of the endometrium include:
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983 Feb;15(1):10-17.
Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022 Apr 9;399(10333):1412-1428.
Mahdy H, Casey MJ, Vadakekut ES, Crotzer D. Endometrial Cancer. 2024 Apr 20. In: StatPearls [Internet]. Treasure Island (FL)
Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983 Feb;15(1):10-7.
Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022 Apr 9;399(10333):1412-1428.
Mahdy H, Casey MJ, Vadakekut ES, Crotzer D. Endometrial Cancer. 2024 Apr 20. In: StatPearls [Internet]. Treasure Island (FL).
National Cancer Institute. Endometrial Cancer Treatment (PDQ®)–Health Professional Version. February 8, 2024. Accessed at www.cancer.gov/types/uterine/hp/endometrial-treatment-pdq/#section/all on July 17, 2024.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Uterine Neoplasms, Version 2.2024. March 6, 2024. Accessed at www.nccn.org/professionals/physician_gls/pdf/uterine.pdf on July 17, 2024.
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Australian National Endometrial Cancer Study Group; et al . Type I and II endometrial cancers: Have they different risk factors? J Clin Oncol. 2013 Jul 10;31(20):2607-18.
Soslow RA, Tornos C, Park KJ, Malpica A, Matias-Guiu X, Oliva E, et al. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S64-S74.
WHO Classification of Tumours Editorial Board. Female Genital Tumours, 5th ed, IARC, 2020. Vol 4.
Last Revised: February 28, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.